DTR fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
DiagnosTear Technologies, Inc. is an ophthalmic company, which engages in the developing and commercializing disruptive diagnostic solutions for better management of eye diseases. Its products include TeaRx Dry Eye, TeaRx Red Eye, and TeaRx Tear Collector. The company was founded on May 10, 2023 and is headquartered in Vancouver, Canada.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
DTR has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company